Rats given LPS injections exhibit a pro-inflammatory response, upregulation of APP and β-secretase, downregulation of Aβ clearance, and cognitive impairment, suggesting a role of chronic inflammation in promoting AD pathology [89] (Fig. 2). This evidence concerns the gene APP and Alzheimer disease.